Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma: Penang General Hospital Experience

  • Phua, Chee Ee (Clinical Oncology Unit, Faculty of Medicine, University of Malaya) ;
  • Tan, Boon Seang (Clinical Oncology Unit, Faculty of Medicine, University of Malaya) ;
  • Tan, Ai Lian (Clinical Oncology Unit, Faculty of Medicine, University of Malaya) ;
  • Eng, Kae Yann (Clinical Oncology Unit, Faculty of Medicine, University of Malaya) ;
  • Ng, Bong Seng (Clinical Oncology Unit, Faculty of Medicine, University of Malaya) ;
  • Malik, Rozita Abdul (Clinical Oncology Unit, Faculty of Medicine, University of Malaya) ;
  • Ishak, Wan Zamaniah Wan (Clinical Oncology Unit, Faculty of Medicine, University of Malaya)
  • Published : 2012.07.31
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: To study the overall treatment time (OTT) and acute toxicity of intensity-modulated radiotherapy (IMRT) treatment for nasopharyngeal carcinoma (NPC). Methods: This retrospective study covered all NPC patients who underwent radical IMRT treatment at the Penang General Hospital from June 2011 to February 2012. Patients of any age and stage of disease with histologically proven diagnosis were included. Information was collected on patient demographics, clinical stage, treatment received, including any neoadjuvant and/or concurrent chemotherapy, acute toxity and completion of IMRT within the OTT. Results: A total of 26 NPC patients were treated with IMRT during the study period; 88.5% had stage III/IV disease. 45.2% received neo-adjuvant chemotherapy while 50.0% were given concurrent chemo-irradiation. All patients completed the treatment and 92.3% within the 7 weeks OTT. Xerostomia was present in all patients with 92.3% having grade 2. Severe grade III/IV acute toxicity occurred in 73.1% of patients, the commonest of which was oral mucositis (57.6%). This was followed by dysphagia which occurred in 53.8%, skin reactions in 42.3% and weight loss in 19.2%. However, haematological toxicity was mild with only one patient having leucopaenia. Conclusion: IMRT treatment for NPC is feasible in our center. More importantly, it can be delivered within the 7 weeks OTT in the majority of patients. Severe grade 3/4 toxicity is very common (73.1%) and thus maximal nutritional and analgesic support is required throughout the treatment.

Keywords

References

  1. Al-Sarraf M, Pajak TF, Cooper JS, et al (1990). Chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma: a radiation therapy oncology group study. J Clin Oncol, 8, 1342-51.
  2. Ali H, al-Sarraf M (1999). Nasopharyngeal cancer. Hematol Oncol Clin North Am, 13, 837-48. https://doi.org/10.1016/S0889-8588(05)70096-4
  3. Barton MB, Keane TJ, Gadalla T, et al (1992). The effect of treatment interruption on tumour control following radical radiotherapy of laryngeal cancer. Radiother Oncol, 23, 137-143. https://doi.org/10.1016/0167-8140(92)90323-M
  4. Baujat B, Bourhis J, Chan AT, et al (2006). Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients. Int J Radiat Oncol Biol Phy, 64, 47-56. https://doi.org/10.1016/j.ijrobp.2005.06.037
  5. Bese NS, Hendry J, Jeremic B (2007). Effects of prolongations of overall treatment time due to unplanned interruptions during radiotherapy of different tuomur sites and practical methods for compensation. Int J Radiat Oncol Biol Phys, 68, 654-61. https://doi.org/10.1016/j.ijrobp.2007.03.010
  6. Cheng JC, Chao KS, Low D (2001). Comparison of intensity-modulated radiation therapy (IMRT) treatment techniques for nasopharyngeal carcinoma. Int J Cancer, 96, 126-31. https://doi.org/10.1002/ijc.1004
  7. Cox JD, Pajak TF, Marcial VA, et al (1992). Interruptions adversely affect local control and survival with hyperfractionated radiation therapy of carcinomas of the upper respiratory and digestive tracts. New evidence for accelerated proliferation from radiation therapy oncology group protocol 8313. Cancer, 69, 2744-8. https://doi.org/10.1002/1097-0142(19920601)69:11<2744::AID-CNCR2820691119>3.0.CO;2-U
  8. Fowler JF, Lindstrom MJ (1992). Loss of local control with prolongation in radiotherapy. Int J Radiat Oncol Biol Phys, 23, 457-67. https://doi.org/10.1016/0360-3016(92)90768-D
  9. Han L, Lin SJ, Pan JJ, et al (2010). Prognostic factors of 305 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy. Chinese J Cancer, 29, 145-50. https://doi.org/10.5732/cjc.009.10332
  10. Hsu MM, Huang SC, Lynn TC, et al (1982). The survival of patients with nasopharyngeal carcinomas. Otolaryngol Head Neck Surg, 90, 289-95.
  11. Kwong LW, Sham ST, Chua TT, et al (1997). The effect of interruptions and prolonged treatment time in radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 39, 703-10. https://doi.org/10.1016/S0360-3016(97)00339-8
  12. Kwong LW, Sham ST, Leung HT, et al (2006). Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 64, 374-81. https://doi.org/10.1016/j.ijrobp.2005.07.968
  13. Langendijk JA, Leemans CR, Buter J, et al (2004). The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature. J Clin Oncol, 22, 4604-12. https://doi.org/10.1200/JCO.2004.10.074
  14. Lee AW, Law SC, Foo KW, et al (1993). Retrospective analysis of patients with nasopharyngeal carcinoma treated during 1976-1985: survival after local recurrence. Int J Radiat Oncol Biol Phys, 26, 773-82. https://doi.org/10.1016/0360-3016(93)90491-D
  15. Lee AW, Poon YF, Foo KW, et al (1992). Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and pattern of failure. Int J Radiat Oncol Biol Phys, 23, 261-70. https://doi.org/10.1016/0360-3016(92)90740-9
  16. Lee N, Xia P, Quivey JM, et al (2002). Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys, 53, 12-22. https://doi.org/10.1016/S0360-3016(02)02724-4
  17. Lin SJ, Pan JJ, Han L, et al (2009). Nasopharyngeal carcinoma treated with reduced volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series. Int J Radiat Oncol Biol Phys, 75, 1071-8. https://doi.org/10.1016/j.ijrobp.2008.12.015
  18. Lin ZX, Li DR, Chen ZJ, et al (1999). What is the significance of nasal involvement in nasopharyngeal carcinoma? Int J Radiat Oncol Biol Phys, 45, 907-14. https://doi.org/10.1016/S0360-3016(99)00297-7
  19. Luo RX, Tang QX, Guo KP, et al (1994). Comparison of continuous and split-course radiotherapy for nasopharyngeal carcinoma-An analysis of 1446 cases with squamous cell carcinoma grade 3. Int J Radiat Oncol Biol Phys, 30, 1107-9. https://doi.org/10.1016/0360-3016(94)90316-6
  20. Lu HM, Chen JX, Huang BQ, et al (2010). Feasibility and efficacy study of weekly cisplatin with concurrent intensity-modulated radiation therapy for nasopharyngeal carcinoma: preliminary results. Oral Oncology, 46, 743-47. https://doi.org/10.1016/j.oraloncology.2010.08.001
  21. Maciejewski B, Preuus-Bayer G, Trott KR (1983). The influence of the number of fractions and of OTT on local control and late complication rate in squamous cell carcinoma of the larynx. Int J Radiat Oncol Biol Phys, 9, 321-8. https://doi.org/10.1016/0360-3016(83)90290-0
  22. Maciejewski B, Withers HR, Taylor JM, et al (1989). Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx: tumor dose-response and repopulation. Int J Radiat Oncol Biol Phys, 16, 831-43. https://doi.org/10.1016/0360-3016(89)90503-8
  23. Malaysian Cancer Statistics-Data and Figure Peninsular Malaysia (2006). National Cancer Registry, Ministry of Health Malaysia.
  24. Ng WT, Lee CH, Hung WM, et al (2011). Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 79, 420-8. https://doi.org/10.1016/j.ijrobp.2009.11.024
  25. Phua CE, Tan BS, Yong TK, et al (2011). Retrospective analysis of results of treatment for nasopharyngeal carcinoma in penang general hospital from 2001-2005. Asian Pacific J Cancer Prev, 12, 3197-200.
  26. Prasad U and Pua KC, 2000. Nasopharyngeal carcinoma: a delay in diagnosis. Med J Malaysia, 55, 230-5.
  27. Pua KC, Khoo SB, Yap YY, et al (2008). Nasopharyngeal carcinoma database. Med J Malaysia, 63, 59-62.
  28. Qin DX, Hu YH, Yan JH, et al (1998). Analysis of 1379 patients with nasopharyngeal carcinoma treated by radiation. Cancer, 61, 1117-24.
  29. Shu-Chen H (1980). Nasopharyngeal cancer: a review of 1605 patients treated radically with cobalt 60. Int J Radiat Oncol Biol Phys, 6, 401-7. https://doi.org/10.1016/0360-3016(80)90052-8
  30. Slevin NJ, Hendry JH, Roberts SA, et al (1992). The effect of increasing the treatment time beyond three weeks on the control of T2 and T3 laryngeal cancer using radiotherapy. Radiother Oncol, 24, 215-20. https://doi.org/10.1016/0167-8140(92)90226-K
  31. Terence PF, Fernando LD, Roberto AL, et al (2003). Prognostic factors and outcome for nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg, 129, 794-9. https://doi.org/10.1001/archotol.129.7.794
  32. Trott KR (2009). Cell repopulation and overall treatment time. Int J Radiat Oncol Biol Phys, 19, 1071-5.
  33. Van den Bogaert W,Van der Leest A, Rijnders A, et al (1995). Does tumor control decrease by prolonging overall treatment time or interrupting treatment in laryngeal cancer? Radiother Oncol, 36, 177-82. https://doi.org/10.1016/0167-8140(95)01597-A
  34. Vikram B, Mishra UB, Strong EW, et al (1985). Patterns of failure in carcinoma of the nasopharynx: I. Failure at the primary site. Int J Radiat Oncol Biol Phys, 11, 1455-9. https://doi.org/10.1016/0360-3016(85)90332-3
  35. Waldron J, Tin MM, Keller A, et al (2003). Limitations of conventional two dimensional radiation therapy planning in nasopharyngeal carcinoma. Radiother Oncol, 68, 153-61. https://doi.org/10.1016/S0167-8140(02)00370-5
  36. Wang DC, Cai WM, Hu YH, et al (1998). Long term survival of 1035 cases of nasopharyngeal carcinoma. Cancer, 61, 2338-41.
  37. Wang JH, Shi M, Hsia YS, et al (2012). Failure patterns and survival in patients with nasopharyngeal carcinoma treated with intensity modulated radiation in Northwest China: A pilot study. Radiation Oncology, 7, 2. https://doi.org/10.1186/1748-717X-7-2
  38. Zelefsky MJ, Harrison LB, Armstrong JG, et al (1992). Long-term treatment results of postoperative radiation therapy for advanced stage oropharyngeal carcinoma. Cancer, 70, 2388-95. https://doi.org/10.1002/1097-0142(19921115)70:10<2388::AID-CNCR2820701003>3.0.CO;2-M

Cited by

  1. Treatment Outcome for Nasopharyngeal Carcinoma in University Malaya Medical Centre from 2004-2008 vol.14, pp.8, 2013, https://doi.org/10.7314/APJCP.2013.14.8.4567